1. Effects of the peripheral CB1 receptor antagonist JD5037 in mono— and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension
   Patryk Remiszewski et al, 2022, Frontiers in Pharmacology CrossRef
2. Ginseng-Sanqi-Chuanxiong (GSC) extracts attenuate d-galactose-induced vascular aging in mice via inhibition of endothelial progenitor cells senescence
   Yinan Liu et al, 2024, Heliyon CrossRef
3. Current Management and Future Directions for Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
   Ahmed Mahmoud et al, 2023, Journal of Personalized Medicine CrossRef
4. Role of endothelial dysfunction in the severity of COVID‑19 infection (Review)
   Tanya Kadiyska et al, 2022, Molecular Medicine Reports CrossRef
5. The role and mechanism of AMPK in pulmonary hypertension
   Jing Hou et al, 2024, Therapeutic Advances in Respiratory Disease CrossRef
6. AMPK activation by metformin protects against pulmonary hypertension in rats and relaxes isolated human pulmonary artery
   Heba Abdelazeem et al, 2023, European Journal of Pharmacology CrossRef
7. Novel and emerging therapies in pulmonary arterial hypertension
   Steven J. Cassady et al, 2022, Frontiers in Drug Discovery CrossRef
8. The Correlation between Lung Ultrasound and Pathology in Rat Model of Monocrotaline‐Induced Pulmonary Hypertension
   Yan-Fen Zhong et al, 2024, Canadian Respiratory Journal CrossRef
9. Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension
   Federico Luongo et al, 2022, Heart Failure Reviews CrossRef
10. AMPK and Pulmonary Hypertension: Crossroads Between Vasoconstriction and Vascular Remodeling
    Qiang Zhao et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
11. Metformin Is Associated with the Inhibition of Renal Artery AT1R/ET-1/iNOS Axis in a Rat Model of Diabetic Nephropathy with Suppression of Inflammation and Oxidative Stress and Kidney Injury
    Amal F. Dawood et al, 2022, Biomedicines CrossRef
12. Lessons from Cancer Metabolism for Pulmonary Arterial Hypertension and Fibrosis
    SeungHye Han et al, 2021, American Journal of Respiratory Cell and Molecular Biology CrossRef
13. Buspirone Induces Weight Loss and Normalization of Blood Pressure via the Stimulation of PPARδ Dependent Energy Producing Pathway in Spontaneously Hypertensive Rats
    Yong-Jik Lee et al, 2023, PPAR Research CrossRef
14. Salt-inducible kinases: new players in pulmonary arterial hypertension?
    Tatiana António et al, 2022, Trends in Pharmacological Sciences CrossRef
15. 1,2-Dehydropyrrolizidine Alkaloids: Their Potential as a Dietary Cause of Sporadic Motor Neuron Diseases
    John A. Edgar et al, 2022, Chemical Research in Toxicology CrossRef
16. AMPK Activation Protects Against Pulmonary Hypertension in Rats and Relaxes Isolated Human Pulmonary Artery
    Heba Abdelazeem et al, SSRN Electronic Journal CrossRef